Healthtech Startups

Lotus makes a wearable ring that controls smart home devices through pointing gestures, requiring no app, WiFi setup, or complex installation. It is designed as assistive technology for home control and independence.

3 investors

Lovon is an AI-powered voice-based therapist that provides on-demand emotional and relationship support through phone calls, designed as a supplement to traditional therapy rather than a replacement. The service helps individuals and couples process stress, navigate conflicts, and build healthier relationships using evidence-based clinical methods.

3 investors

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.

3 investors

Luma Vision develops advanced imaging technologies focused on cardiology to provide cardiologists with comprehensive, evidence-based understanding of patient heart conditions. The company serves healthcare providers and addresses unmet clinical needs in cardiac imaging.

3 investors

Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care. It serves health systems across ambulatory, inpatient/hospital-at-home, and perioperative settings to reduce manual work for care teams and close gaps in care.

3 investors

Lumia builds smart earring wearables (Lumia 2) that continuously track over 20 health metrics — including blood flow, sleep stages, readiness, hormonal cycle, and activity — via sensors placed in the ear, paired with a companion app. The consumer device is designed to look like jewelry and targets individuals tracking their health, energy, recovery, and cycle patterns.

3 investors

Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.

3 investors

Lumira Ventures is a venture capital firm that invests in biotherapeutic and medical device companies developing innovative therapeutic solutions for patients. The firm focuses on companies creating disruptive treatments, addressing unmet medical needs, improving outcomes, and reducing healthcare costs.

3 investors

Lumitron Technologies develops laser-Compton light sources that produce monochromatic x-ray and gamma-ray outputs for ultrahigh-fidelity imaging, ultra-low dose radiography, and precision radiotherapy. Its technology targets medical applications such as FLASH radiotherapy and k-edge subtraction imaging, as well as element- and isotope-specific material identification.

3 investors

Lumius develops a 3D ultrasound device designed to provide fast, smart, and accessible imaging capabilities. The device functions as a 3D camera for internal body visualization, serving the medical imaging market.

3 investors

Lumos provides evaluation and data services—including supervised fine-tuning pairs, human and AI feedback, preference ranking, and reinforcement learning—to improve the accuracy and safety of AI models for health and life sciences. It works with foundational AI labs, startups, and governments, and its team has delivered projects for OpenAI, Google, and Meta.

3 investors

Lumosity offers a brain-training program that adapts lab-based cognitive tasks into games, providing users with progress tracking, feedback, and insights into their cognition. The program adjusts to each user's age, skill level, and cognitive strengths and weaknesses.

3 investors

Luna develops a small patch pump with automated insulin dosing for insulin pen users to help manage glucose levels overnight. The device uses a closed-loop algorithm to adjust insulin doses automatically while users sleep.

3 investors

Lupeng Pharmaceutical develops next-generation small-molecule targeted drugs for malignant tumors and autoimmune diseases, focusing on hematologic cancer targets such as BTK, Bcl-2, and Bcl-xL, with multi-center clinical development and commercialization in international and Chinese markets. Its lead drug rocbrutinib (Lukeda) has received NMPA approval for market in China.

3 investors

Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise. The company focuses on pharmaceutical development in the oncology and dermatology space.

3 investors

LUUM provides AI-powered lash extension services using robotic technology to apply lashes consistently and safely, staffed by lash artists. The service targets consumers seeking fast, comfortable beauty treatments.

3 investors

Luxsonic Healthcare develops enterprise imaging and clinical simulation software for health systems, including a unified imaging platform with web workflows, VR reading environments, and cloud-native PACS, plus immersive VR simulation for medical education and training. It serves clinicians, residents, and medical institutions across North America.

3 investors

Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.

3 investors

Lyfegen provides a software platform for managing value-based and outcome-based healthcare contracts and drug pricing agreements between pharmaceutical companies, health insurers (payers), and providers.

3 investors

Lynk Pharma develops pharmaceutical products for rheumatoid arthritis and ankylosing spondylitis, with selective licensing arrangements for regional commercialization.

3 investors

LynxCare enables hospitals and life sciences organizations to generate clinical insights from harmonized real-world health datasets. The company supports clinical research and real-world evidence generation for European health systems through data science, healthcare informatics, and AI capabilities.

3 investors

Lynxight connects standard security cameras to an AI system that detects drowning risks and safety incidents at commercial pools, sending alerts to lifeguards via smartwatches and workstations. It serves pool operators for both lifeguard-attended and remotely supervised pools, and operates in 16 countries.

3 investors

Lyrebird is a web-based clinical AI platform that records patient consultations and generates customisable clinical notes, letters, and documents that integrate with clinicians' existing EMR systems. It serves doctors and medical practices in Australia, supporting in-person and telehealth (phone and video) consults.

3 investors

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

3 investors